2021-2022 Regular SessionIllinois Legislature

HB3630: INS-PHARMACY BENEFIT MANAGERS

Legislative Summary

Amends the Illinois Insurance Code. Provides that if a generic equivalent for a brand name drug is approved by the federal Food and Drug Administration, plans that provide coverage for prescription drugs through the use of a drug formulary that are amended, delivered, issued, or renewed in the State on or after January 1, 2022 shall comply with specified requirements. Provides that the Department of Insurance may adopt rules to implement provisions concerning notice of change of drug formulary. In provisions concerning a contract between a health insurer and a pharmacy benefit manager, provides that a pharmacy benefit manager must update and publish maximum allowable cost pricing information according to specified requirements, must provide a reasonable administrative appeal procedure to allow pharmacies to challenge maximum allowable costs, and must comply with specified requirements if an appeal is denied. Sets forth provisions concerning pharmacy benefit manager contracts; specified requirements that a pharmacy benefit manager shall comply with; and specified requirements that an auditing entity shall comply with when conducting a pharmacy audit. Provides that a violation of specified provisions is an unfair method of competition and unfair and deceptive act or practice in the business of insurance. Sets forth provisions concerning applicability of the Pharmacy Benefit Managers Article of the Illinois Insurance Code, and provisions concerning fiduciary responsibility of a pharmacy benefit manager. Defines terms. Makes other changes. Amends the Illinois Public Aid Code. Sets forth provisions concerning reimbursement of professional dispensing fees and acquisition costs for pharmacy providers.

Bill History

2/19/2021
Filed with the Clerk by Rep. Greg Harris
House of Representatives
2/22/2021
First Reading
House of Representatives
2/22/2021
Referred to Rules Committee
House of Representatives
3/4/2021
Added Co-Sponsor Rep. Bob Morgan
House of Representatives
3/8/2021
Added Chief Co-Sponsor Rep. Sue Scherer
House of Representatives
3/10/2021
Added Co-Sponsor Rep. Jonathan Carroll
House of Representatives
3/10/2021
Added Chief Co-Sponsor Rep. C.D. Davidsmeyer
House of Representatives
3/10/2021
Added Co-Sponsor Rep. Deb Conroy
House of Representatives
3/10/2021
Added Co-Sponsor Rep. Anna Moeller
House of Representatives
3/10/2021
Added Co-Sponsor Rep. Ann M. Williams
House of Representatives
3/10/2021
Added Co-Sponsor Rep. Nicholas K. Smith
House of Representatives
3/10/2021
Added Co-Sponsor Rep. Mark L. Walker
House of Representatives
3/12/2021
Added Co-Sponsor Rep. Patrick Windhorst
House of Representatives
3/12/2021
Added Co-Sponsor Rep. Curtis J. Tarver, II
House of Representatives
3/16/2021
Added Co-Sponsor Rep. Robyn Gabel
House of Representatives
3/16/2021
Added Co-Sponsor Rep. Thomas M. Bennett
House of Representatives
3/16/2021
Added Co-Sponsor Rep. Brad Halbrook
House of Representatives
3/16/2021
Assigned to Prescription Drug Affordability & Accessibility Committee
House of Representatives
3/16/2021
Added Co-Sponsor Rep. Tim Butler
House of Representatives
3/16/2021
Added Co-Sponsor Rep. Janet Yang Rohr
House of Representatives
3/17/2021
Added Co-Sponsor Rep. Daniel Swanson
House of Representatives
3/18/2021
Added Co-Sponsor Rep. Dan Brady
House of Representatives
3/18/2021
Added Co-Sponsor Rep. Dave Severin
House of Representatives
3/18/2021
Added Co-Sponsor Rep. Chris Miller
House of Representatives
3/22/2021
Added Co-Sponsor Rep. Barbara Hernandez
House of Representatives
3/24/2021
Added Chief Co-Sponsor Rep. Dan Caulkins
House of Representatives
3/24/2021
Added Co-Sponsor Rep. Jehan Gordon-Booth
House of Representatives
3/24/2021
Added Co-Sponsor Rep. Charles Meier
House of Representatives
3/26/2021
Added Co-Sponsor Rep. Stephanie A. Kifowit
House of Representatives
3/27/2021
Rule 19(a) / Re-referred to Rules Committee
House of Representatives
3/29/2021
Added Co-Sponsor Rep. David Friess
House of Representatives
3/29/2021
Added Co-Sponsor Rep. Amy Grant
House of Representatives
4/1/2021
Added Co-Sponsor Rep. Bradley Stephens
House of Representatives
4/14/2021
Added Co-Sponsor Rep. Delia C. Ramirez
House of Representatives
4/21/2021
Added Co-Sponsor Rep. Mike Murphy
House of Representatives
1/5/2022
Assigned to Prescription Drug Affordability & Accessibility Committee
House of Representatives
1/7/2022
Added Co-Sponsor Rep. Anthony DeLuca
House of Representatives
1/31/2022
Added Co-Sponsor Rep. Amy Elik
House of Representatives
2/18/2022
Rule 19(a) / Re-referred to Rules Committee
House of Representatives